Trial Profile
A randomized phase I/II placebo-controlled study of amdoxovir (DAPD) versus placebo together with enfuvirtide (T-20) plus optimized background therapy for HIV-infected subjects failing current therapy
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Amdoxovir (Primary) ; Enfuvirtide
- Indications HIV infections; HIV-1 infections
- Focus Therapeutic Use
- 09 Oct 2006 Status change
- 24 Oct 2005 New trial record.